← Privia Health Group, Inc. PRVA
Market Price
$21.98
Market Cap
$2.74B
P/E Ratio
N/A
Revenue (FY 2026)
↓-77.5% YoY
$477.39M
3-Yr CAGR: -34.0%
Net Income
$22.92M
Net Margin: N/A
Free Cash Flow
↓-85.0% YoY
$24.41M
FCF Yield: 0.89%
EPS (Diluted)
↓-322.2% YoY
$-0.40
Basic: $-0.40
Return on Equity
Efficiency
3.1%
ROA: 6.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (PRVA)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $786.4M | — | $57.9M | $7.9M | — | $0.09 | — | $24.4M | — | — |
| FY 2020 | $817.1M | +3.9% | $621.0M | $31.2M | +293.3% | $0.33 | +266.7% | $38.9M | $38.5M | — |
| FY 2021 | $966.2M | +18.3% | $761.6M | $-188.2M | -702.5% | $-1.83 | -654.5% | $55.1M | $54.5M | +41.5% |
| FY 2022 | $1,356.7M | +40.4% | $134.8M | $-8.6M | +95.4% | $-0.08 | +95.6% | $47.2M | $47.1M | -13.6% |
| FY 2023 | $1,657.7M | +22.2% | $161.5M | $23.1M | +368.8% | $0.19 | +337.5% | $80.8M | $80.7M | +71.3% |
| FY 2024 | $1,736.4M | +4.7% | $176.9M | $14.4M | -37.7% | $0.11 | -42.1% | $109.3M | $108.5M | +34.5% |
| FY 2025 | $2,122.8M | +22.3% | $209.4M | $22.9M | +59.3% | $0.18 | +63.6% | $163.4M | $162.2M | +49.4% |
| FY 2026 | $477.4M | -77.5% | $162.1M | — | — | $-0.40 | -322.2% | $25.8M | $24.4M | -85.0% |
Valuation
Market Price
$21.98
Market Cap
$2.74B
Enterprise Value
$2.37B
P/E Ratio
N/A
P/B Ratio
3.76
FCF Yield
0.89%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
33.95%
Operating Margin
-5.88%
Net Margin
N/A
Return on Equity (ROE)
3.11%
Return on Assets (ROA)
6.00%
Asset Turnover
1.25x
Revenue 3-Yr CAGR
-33.96%
Financial Health & Liquidity
Current Ratio
1.25
Cash Ratio
4.35
Debt / Equity
0.152
Debt / Assets
0.294
Cash & Equivalents
$479.69M
Total Debt
$112.42M
Book Value / Share
$5.85
Cash Flow Efficiency
Operating Cash Flow
$25.83M
Capital Expenditures (CapEx)
$1.42M
Free Cash Flow
$24.41M
OCF / Revenue
5.41%
FCF / Revenue
5.11%
FCF 3-Yr CAGR
-32.87%
Per Share Metrics
EPS (Diluted)
$-0.40
EPS (Basic)
$-0.40
Dividends / Share
N/A
Book Value / Share
$5.85
EPS YoY Growth
-322.22%
Balance Sheet (FY 2026)
Total Assets
$381.96M
Total Liabilities
$239.27M
Stockholders' Equity
$737.22M
Current Assets
$138.24M
Current Liabilities
$110.33M